New Research Links Cognizin Citicoline to Neuromuscular Health

Researchers at the Institute of Health Sciences, a division of Kirin Holdings, utilized an in vitro cell model to examine how the branded ingredient influences the development of the neuromuscular junction. By employing gene expression analysis and immunofluorescence, the team monitored acetylcholine receptor clustering—a vital process for functional muscle activation. These results point toward a bridge between cognitive health ingredients and physical performance, a shift that aligns with growing consumer interest in the mind-body connection.

Karen Todd, vice president of global brand marketing at Kyowa Hakko USA, noted that this study reflects a demand for rigorous scientific validation in the supplement industry. The findings are scheduled for presentation on July 27, 2026, at the American Society for Nutrition’s NUTRITION 2026 conference in National Harbor, Maryland. Lead author Chihiro Ono will present the data, titled "Citicoline May Strengthen Formation of Neuromuscular Junction by Enhancing Acetylcholine Receptor Clustering in Co-Culture With Neurons and Skeletal Muscle Cells," during the event's sports nutrition session. For manufacturers, the research marks a potential expansion for Cognizin beyond traditional cognitive support into the broader functional aging and athletic recovery markets.